Anne Wojcicki, co-founder and former CEO of 23andMe, through her nonprofit TTAM Research Institute, has won a bidding war to purchase most of 23andMe’s assets for $305 million. This new agreement overrides Regeneron's previous $256 million bid. TTAM commits to preserving customer privacy and allowing data deletion options, with court approval pending. Wojcicki aims to further 23andMe’s mission of accessible genomic understanding and health benefits.